Showing 67,941 - 67,960 results of 107,763 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( e ((non decrease) OR (point decrease)) ))', query time: 2.11s Refine Results
  1. 67941

    Table2_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx... by Jalene Nalbant (17269828)

    Published 2023
    “…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m<sup>−2</sup> yr<sup>−1</sup>) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m<sup>−2</sup> yr<sup>−1</sup>) in the Early Holocene. …”
  2. 67942

    Table1_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx... by Jalene Nalbant (17269828)

    Published 2023
    “…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m<sup>−2</sup> yr<sup>−1</sup>) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m<sup>−2</sup> yr<sup>−1</sup>) in the Early Holocene. …”
  3. 67943

    Table3_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx... by Jalene Nalbant (17269828)

    Published 2023
    “…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m<sup>−2</sup> yr<sup>−1</sup>) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m<sup>−2</sup> yr<sup>−1</sup>) in the Early Holocene. …”
  4. 67944

    Table4_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx... by Jalene Nalbant (17269828)

    Published 2023
    “…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m<sup>−2</sup> yr<sup>−1</sup>) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m<sup>−2</sup> yr<sup>−1</sup>) in the Early Holocene. …”
  5. 67945

    Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  6. 67946

    DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  7. 67947

    Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  8. 67948

    Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  9. 67949

    DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  10. 67950

    Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  11. 67951

    Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  12. 67952

    DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  13. 67953

    Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  14. 67954

    DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  15. 67955

    Impairment of RPA foci formation and the DNA damage checkpoint in CBP and p300 depleted cells. by Hideaki Ogiwara (18358)

    Published 2012
    “…(<b>D, E</b>) Decreased DNA damage-induced chromatin binding of RPA proteins in H1299 cells. …”
  16. 67956

    Breadth and magnitude of CD8<sup>+</sup> T-cell IFN-γ responses to clade-B consensus and autologous HIV-1 Nef peptides. by Mehrnoosh Doroudchi (118450)

    Published 2012
    “…The negative control = non-stimulated, positive control tube = (SEB) used <i>Staphylococcus aureus</i> Enterotoxin B superantigen as stimulant. …”
  17. 67957
  18. 67958

    Data Sheet 1_Prevalence of fungal colonization among patients with psoriasis in difficult-to-treat areas: impact of apremilast on mycotic burden and clinical outcomes.pdf by Elena Campione (8906858)

    Published 2024
    “…Finally, improvements in clinical scores i.e., PASI, NAPSI, DLQI, itch VAS, PAIN VAS, scPGA and sPGA-G and biochemical serum profile, as well as a significant decrease in serum IL-17A, TGF-β 1 and IL-10 levels (from 8.51 to 4.16 pg/mL; from 66.10 to 48.70 ng/mL and from 20.05 to 14 pg/mL, respectively) were observed in all patients.…”
  19. 67959
  20. 67960